Tensordyne
PrivateLast Round
Series C
Feb 20, 2024
Est. Valuation
$500M
Total Funding Raised
$175.9M
Company Overview
Tensordyne is a developer of high-performance, low-power artificial intelligence inference systems for data centers, serving hyperscalers and neocloud providers.
Sector
AI, Data & Cloud Infrastructure
Verticals
Computing Hardware, ML Platforms, Semiconductors, Cloud Infrastructure
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tensordyne Comps
Public and private peers based on sector, stage, and business model.
Tensordyne Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Feb 20, 2024 | ||||
| Series B | Feb 17, 2021 | ||||
| Series A | Jul 31, 2019 |
Key People
Founding team and executive leadership
Tensordyne Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GreatPoint Ventures | Series B, Series A, Series C |
| TASARU Mobility Investments | Series C |
| WRVI Capital | Series B, Series C |
| Pledge Ventures | Series C |
| Robert Bosch Venture Capital | Series B |
| Fluxunit | Series B, Series A |
| Continental AG | Series B |
Tensordyne Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Tensordyne's valuation, stock price, and market status.
